Patent · US Active

Methods and products for genetic engineering

US12202860B2 · kind B2 · utility

1Cited by
4References
27Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 3, 2023
Grant dateJan 21, 2025
Priority date
Expiry dateApr 3, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to a virus-derived particle comprising one or more Cas protein(s), as well as to kits and methods using the same for altering a target nucleic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.